SPL026 (DMT fumarate) is currently going through section II medical trials investigating its use alongside supportive psychotherapy as a possible treatment method for important depressive disorder. The hope would be that the First trial, which aims to determine the bottom dose of DMT that elicits a psychedelic experience, could start https://dmt15825.webbuzzfeed.com/27736476/the-ultimate-guide-to-dmt